A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure
The blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and reduced sodium intake are well established. The effects on other biomarkers related to vascular health are of interest and might assist in explaining the effects of the DASH diet and sodium...
Gespeichert in:
Veröffentlicht in: | The Journal of nutrition 2021-10, Vol.151 (10), p.3067-3074 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3074 |
---|---|
container_issue | 10 |
container_start_page | 3067 |
container_title | The Journal of nutrition |
container_volume | 151 |
creator | Sullivan, Valerie K Appel, Lawrence J Seegmiller, Jesse C McClure, Scott T Rebholz, Casey M |
description | The blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and reduced sodium intake are well established. The effects on other biomarkers related to vascular health are of interest and might assist in explaining the effects of the DASH diet and sodium reduction.
We hypothesized that a low-sodium DASH diet improves (lowers) biomarkers of inflammation [C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR)] and mineral metabolism [phosphorus and fibroblast growth factor-23 (FGF23)].
We conducted a secondary analysis of the DASH-Sodium trial using frozen serum samples. This controlled feeding study randomly assigned 412 adults (≥22 y) with elevated blood pressure (120–159/80–95 mmHg) to consume either a DASH diet or control diet. Within each arm, participants received 3 sodium levels [low (1150 mg), intermediate (2300 mg), high (3450 mg)] in random sequence, each for 30 d. To maximize contrast, samples collected at the end of the low-sodium DASH (n = 198) and high-sodium control (n = 194) diets were compared. Between-diet differences in serum CRP, suPAR, phosphorus, and FGF23 concentrations were assessed using linear regression adjusted for age, sex, race, income, education, smoking status, and BMI.
CRP concentrations did not differ between groups (P = 0.83), but suPAR was higher after the low-sodium DASH diet than the high-sodium control [geometric mean 2470 pg/mL (95% CI: 2380, 2560 pg/mL), compared with 2290 pg/mL (95% CI: 2210, 2380 pg/mL); P = 0.006]. Phosphorus was higher after the low-sodium DASH diet [geometric mean 3.50 mg/dL (95% CI: 3.43, 3.57 mg/dL)] compared with the high-sodium control diet [geometric mean 3.39 mg/dL (95% CI: 3.33, 3.46 mg/dL); P = 0.04]. FGF23 was also higher after the low-sodium DASH diet [geometric mean 35.3 pg/mL (95% CI: 33.3, 37.3 pg/mL) compared with 28.2 pg/mL (95% CI: 26.6, 29.8 pg/mL); P < 0.001].
Contrary to our hypothesis, biomarkers of inflammation and mineral metabolism were increased or unchanged by a low-sodium DASH diet compared with a high-sodium control diet in adults with elevated blood pressure. |
doi_str_mv | 10.1093/jn/nxab236 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8485900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/jn/nxab236</oup_id><els_id>S0022316622003753</els_id><sourcerecordid>2581072346</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-dc14df370a4ace13b4bc19cae696777dbaa18265e35c5de58db76dc62c45f2503</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYNY7Fp98QNIQAQRxubv_HkR1ra2hV0srD6HTHLHZp1J1mRmqx_A723KbksV8ek-3N85nHsPQi8oeUdJw4_X_tj_0C3j5SM0o1LQoqSEPEYzQhgrOC3LQ_Q0pTUhhIqmfoIOuWANp6yaoV9zvAg3xSpYNw34dL66wKcORh1_4is9jhA9nncdmDHhFcSMLHX8BjHh0OFL3_V6GPTogsfaW7x0HqLu8TIbtKF3acAu6-3UZ_mNG6_xWQ9bPYLFH_oQLL6KkNIU4Rk66HSf4Pl-HqEvH88-n1wUi0_nlyfzRWFETcfCGipsxyuihTZAeStaQxujoWzKqqpsqzWtWSmBSyMtyNq2VWlNyYyQHZOEH6H3O9_N1A5gDfgx51Wb6IZ8sQraqT833l2rr2GralHLhtwavNkbxPB9gjSqwSUDfa89hCkpJqWklAjJMvrqL3QdpujzeZmqKakYF2Wm3u4oE0NKEbr7MJSo23bV2qt9uxl--TD-PXpXZwZe74Awbf5vJHYc5GdvHUSVjANvwLqYu1Y2uH_JfgPbBcHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581072346</pqid></control><display><type>article</type><title>A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sullivan, Valerie K ; Appel, Lawrence J ; Seegmiller, Jesse C ; McClure, Scott T ; Rebholz, Casey M</creator><creatorcontrib>Sullivan, Valerie K ; Appel, Lawrence J ; Seegmiller, Jesse C ; McClure, Scott T ; Rebholz, Casey M</creatorcontrib><description>The blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and reduced sodium intake are well established. The effects on other biomarkers related to vascular health are of interest and might assist in explaining the effects of the DASH diet and sodium reduction.
We hypothesized that a low-sodium DASH diet improves (lowers) biomarkers of inflammation [C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR)] and mineral metabolism [phosphorus and fibroblast growth factor-23 (FGF23)].
We conducted a secondary analysis of the DASH-Sodium trial using frozen serum samples. This controlled feeding study randomly assigned 412 adults (≥22 y) with elevated blood pressure (120–159/80–95 mmHg) to consume either a DASH diet or control diet. Within each arm, participants received 3 sodium levels [low (1150 mg), intermediate (2300 mg), high (3450 mg)] in random sequence, each for 30 d. To maximize contrast, samples collected at the end of the low-sodium DASH (n = 198) and high-sodium control (n = 194) diets were compared. Between-diet differences in serum CRP, suPAR, phosphorus, and FGF23 concentrations were assessed using linear regression adjusted for age, sex, race, income, education, smoking status, and BMI.
CRP concentrations did not differ between groups (P = 0.83), but suPAR was higher after the low-sodium DASH diet than the high-sodium control [geometric mean 2470 pg/mL (95% CI: 2380, 2560 pg/mL), compared with 2290 pg/mL (95% CI: 2210, 2380 pg/mL); P = 0.006]. Phosphorus was higher after the low-sodium DASH diet [geometric mean 3.50 mg/dL (95% CI: 3.43, 3.57 mg/dL)] compared with the high-sodium control diet [geometric mean 3.39 mg/dL (95% CI: 3.33, 3.46 mg/dL); P = 0.04]. FGF23 was also higher after the low-sodium DASH diet [geometric mean 35.3 pg/mL (95% CI: 33.3, 37.3 pg/mL) compared with 28.2 pg/mL (95% CI: 26.6, 29.8 pg/mL); P < 0.001].
Contrary to our hypothesis, biomarkers of inflammation and mineral metabolism were increased or unchanged by a low-sodium DASH diet compared with a high-sodium control diet in adults with elevated blood pressure.</description><identifier>ISSN: 0022-3166</identifier><identifier>EISSN: 1541-6100</identifier><identifier>DOI: 10.1093/jn/nxab236</identifier><identifier>PMID: 34293127</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Adults ; Biomarkers ; Blood Pressure ; C-reactive protein ; cardiovascular ; DASH ; Diet ; Diet, Sodium-Restricted ; Dietary Approaches To Stop Hypertension ; Dietary intake ; Dietary supplements ; Fibroblast growth factor 23 ; Growth factors ; Humans ; Hypertension ; Inflammation ; Mineral metabolism ; Minerals ; Nutrient deficiency ; Nutrition and Disease ; Nutrition research ; Phosphorus ; Pressure effects ; Secondary analysis ; Sodium ; soluble urokinase plasminogen activator receptor ; U-Plasminogen activator ; Urokinase</subject><ispartof>The Journal of nutrition, 2021-10, Vol.151 (10), p.3067-3074</ispartof><rights>2021 American Society for Nutrition.</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition. 2021</rights><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.</rights><rights>Copyright American Institute of Nutrition Oct 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-dc14df370a4ace13b4bc19cae696777dbaa18265e35c5de58db76dc62c45f2503</citedby><cites>FETCH-LOGICAL-c481t-dc14df370a4ace13b4bc19cae696777dbaa18265e35c5de58db76dc62c45f2503</cites><orcidid>0000-0002-2321-0188 ; 0000-0002-5442-8745 ; 0000-0002-0673-6823 ; 0000-0002-9752-3152</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34293127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sullivan, Valerie K</creatorcontrib><creatorcontrib>Appel, Lawrence J</creatorcontrib><creatorcontrib>Seegmiller, Jesse C</creatorcontrib><creatorcontrib>McClure, Scott T</creatorcontrib><creatorcontrib>Rebholz, Casey M</creatorcontrib><title>A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure</title><title>The Journal of nutrition</title><addtitle>J Nutr</addtitle><description>The blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and reduced sodium intake are well established. The effects on other biomarkers related to vascular health are of interest and might assist in explaining the effects of the DASH diet and sodium reduction.
We hypothesized that a low-sodium DASH diet improves (lowers) biomarkers of inflammation [C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR)] and mineral metabolism [phosphorus and fibroblast growth factor-23 (FGF23)].
We conducted a secondary analysis of the DASH-Sodium trial using frozen serum samples. This controlled feeding study randomly assigned 412 adults (≥22 y) with elevated blood pressure (120–159/80–95 mmHg) to consume either a DASH diet or control diet. Within each arm, participants received 3 sodium levels [low (1150 mg), intermediate (2300 mg), high (3450 mg)] in random sequence, each for 30 d. To maximize contrast, samples collected at the end of the low-sodium DASH (n = 198) and high-sodium control (n = 194) diets were compared. Between-diet differences in serum CRP, suPAR, phosphorus, and FGF23 concentrations were assessed using linear regression adjusted for age, sex, race, income, education, smoking status, and BMI.
CRP concentrations did not differ between groups (P = 0.83), but suPAR was higher after the low-sodium DASH diet than the high-sodium control [geometric mean 2470 pg/mL (95% CI: 2380, 2560 pg/mL), compared with 2290 pg/mL (95% CI: 2210, 2380 pg/mL); P = 0.006]. Phosphorus was higher after the low-sodium DASH diet [geometric mean 3.50 mg/dL (95% CI: 3.43, 3.57 mg/dL)] compared with the high-sodium control diet [geometric mean 3.39 mg/dL (95% CI: 3.33, 3.46 mg/dL); P = 0.04]. FGF23 was also higher after the low-sodium DASH diet [geometric mean 35.3 pg/mL (95% CI: 33.3, 37.3 pg/mL) compared with 28.2 pg/mL (95% CI: 26.6, 29.8 pg/mL); P < 0.001].
Contrary to our hypothesis, biomarkers of inflammation and mineral metabolism were increased or unchanged by a low-sodium DASH diet compared with a high-sodium control diet in adults with elevated blood pressure.</description><subject>Adult</subject><subject>Adults</subject><subject>Biomarkers</subject><subject>Blood Pressure</subject><subject>C-reactive protein</subject><subject>cardiovascular</subject><subject>DASH</subject><subject>Diet</subject><subject>Diet, Sodium-Restricted</subject><subject>Dietary Approaches To Stop Hypertension</subject><subject>Dietary intake</subject><subject>Dietary supplements</subject><subject>Fibroblast growth factor 23</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Inflammation</subject><subject>Mineral metabolism</subject><subject>Minerals</subject><subject>Nutrient deficiency</subject><subject>Nutrition and Disease</subject><subject>Nutrition research</subject><subject>Phosphorus</subject><subject>Pressure effects</subject><subject>Secondary analysis</subject><subject>Sodium</subject><subject>soluble urokinase plasminogen activator receptor</subject><subject>U-Plasminogen activator</subject><subject>Urokinase</subject><issn>0022-3166</issn><issn>1541-6100</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV9rFDEUxYNY7Fp98QNIQAQRxubv_HkR1ra2hV0srD6HTHLHZp1J1mRmqx_A723KbksV8ek-3N85nHsPQi8oeUdJw4_X_tj_0C3j5SM0o1LQoqSEPEYzQhgrOC3LQ_Q0pTUhhIqmfoIOuWANp6yaoV9zvAg3xSpYNw34dL66wKcORh1_4is9jhA9nncdmDHhFcSMLHX8BjHh0OFL3_V6GPTogsfaW7x0HqLu8TIbtKF3acAu6-3UZ_mNG6_xWQ9bPYLFH_oQLL6KkNIU4Rk66HSf4Pl-HqEvH88-n1wUi0_nlyfzRWFETcfCGipsxyuihTZAeStaQxujoWzKqqpsqzWtWSmBSyMtyNq2VWlNyYyQHZOEH6H3O9_N1A5gDfgx51Wb6IZ8sQraqT833l2rr2GralHLhtwavNkbxPB9gjSqwSUDfa89hCkpJqWklAjJMvrqL3QdpujzeZmqKakYF2Wm3u4oE0NKEbr7MJSo23bV2qt9uxl--TD-PXpXZwZe74Awbf5vJHYc5GdvHUSVjANvwLqYu1Y2uH_JfgPbBcHg</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Sullivan, Valerie K</creator><creator>Appel, Lawrence J</creator><creator>Seegmiller, Jesse C</creator><creator>McClure, Scott T</creator><creator>Rebholz, Casey M</creator><general>Elsevier Inc</general><general>Oxford University Press</general><general>American Institute of Nutrition</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2321-0188</orcidid><orcidid>https://orcid.org/0000-0002-5442-8745</orcidid><orcidid>https://orcid.org/0000-0002-0673-6823</orcidid><orcidid>https://orcid.org/0000-0002-9752-3152</orcidid></search><sort><creationdate>20211001</creationdate><title>A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure</title><author>Sullivan, Valerie K ; Appel, Lawrence J ; Seegmiller, Jesse C ; McClure, Scott T ; Rebholz, Casey M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-dc14df370a4ace13b4bc19cae696777dbaa18265e35c5de58db76dc62c45f2503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Biomarkers</topic><topic>Blood Pressure</topic><topic>C-reactive protein</topic><topic>cardiovascular</topic><topic>DASH</topic><topic>Diet</topic><topic>Diet, Sodium-Restricted</topic><topic>Dietary Approaches To Stop Hypertension</topic><topic>Dietary intake</topic><topic>Dietary supplements</topic><topic>Fibroblast growth factor 23</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Inflammation</topic><topic>Mineral metabolism</topic><topic>Minerals</topic><topic>Nutrient deficiency</topic><topic>Nutrition and Disease</topic><topic>Nutrition research</topic><topic>Phosphorus</topic><topic>Pressure effects</topic><topic>Secondary analysis</topic><topic>Sodium</topic><topic>soluble urokinase plasminogen activator receptor</topic><topic>U-Plasminogen activator</topic><topic>Urokinase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sullivan, Valerie K</creatorcontrib><creatorcontrib>Appel, Lawrence J</creatorcontrib><creatorcontrib>Seegmiller, Jesse C</creatorcontrib><creatorcontrib>McClure, Scott T</creatorcontrib><creatorcontrib>Rebholz, Casey M</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sullivan, Valerie K</au><au>Appel, Lawrence J</au><au>Seegmiller, Jesse C</au><au>McClure, Scott T</au><au>Rebholz, Casey M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure</atitle><jtitle>The Journal of nutrition</jtitle><addtitle>J Nutr</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>151</volume><issue>10</issue><spage>3067</spage><epage>3074</epage><pages>3067-3074</pages><issn>0022-3166</issn><eissn>1541-6100</eissn><abstract>The blood pressure–lowering effects of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and reduced sodium intake are well established. The effects on other biomarkers related to vascular health are of interest and might assist in explaining the effects of the DASH diet and sodium reduction.
We hypothesized that a low-sodium DASH diet improves (lowers) biomarkers of inflammation [C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR)] and mineral metabolism [phosphorus and fibroblast growth factor-23 (FGF23)].
We conducted a secondary analysis of the DASH-Sodium trial using frozen serum samples. This controlled feeding study randomly assigned 412 adults (≥22 y) with elevated blood pressure (120–159/80–95 mmHg) to consume either a DASH diet or control diet. Within each arm, participants received 3 sodium levels [low (1150 mg), intermediate (2300 mg), high (3450 mg)] in random sequence, each for 30 d. To maximize contrast, samples collected at the end of the low-sodium DASH (n = 198) and high-sodium control (n = 194) diets were compared. Between-diet differences in serum CRP, suPAR, phosphorus, and FGF23 concentrations were assessed using linear regression adjusted for age, sex, race, income, education, smoking status, and BMI.
CRP concentrations did not differ between groups (P = 0.83), but suPAR was higher after the low-sodium DASH diet than the high-sodium control [geometric mean 2470 pg/mL (95% CI: 2380, 2560 pg/mL), compared with 2290 pg/mL (95% CI: 2210, 2380 pg/mL); P = 0.006]. Phosphorus was higher after the low-sodium DASH diet [geometric mean 3.50 mg/dL (95% CI: 3.43, 3.57 mg/dL)] compared with the high-sodium control diet [geometric mean 3.39 mg/dL (95% CI: 3.33, 3.46 mg/dL); P = 0.04]. FGF23 was also higher after the low-sodium DASH diet [geometric mean 35.3 pg/mL (95% CI: 33.3, 37.3 pg/mL) compared with 28.2 pg/mL (95% CI: 26.6, 29.8 pg/mL); P < 0.001].
Contrary to our hypothesis, biomarkers of inflammation and mineral metabolism were increased or unchanged by a low-sodium DASH diet compared with a high-sodium control diet in adults with elevated blood pressure.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34293127</pmid><doi>10.1093/jn/nxab236</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-2321-0188</orcidid><orcidid>https://orcid.org/0000-0002-5442-8745</orcidid><orcidid>https://orcid.org/0000-0002-0673-6823</orcidid><orcidid>https://orcid.org/0000-0002-9752-3152</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3166 |
ispartof | The Journal of nutrition, 2021-10, Vol.151 (10), p.3067-3074 |
issn | 0022-3166 1541-6100 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8485900 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Adults Biomarkers Blood Pressure C-reactive protein cardiovascular DASH Diet Diet, Sodium-Restricted Dietary Approaches To Stop Hypertension Dietary intake Dietary supplements Fibroblast growth factor 23 Growth factors Humans Hypertension Inflammation Mineral metabolism Minerals Nutrient deficiency Nutrition and Disease Nutrition research Phosphorus Pressure effects Secondary analysis Sodium soluble urokinase plasminogen activator receptor U-Plasminogen activator Urokinase |
title | A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A13%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Low-Sodium%20DASH%20Dietary%20Pattern%20Affects%20Serum%20Markers%20of%20Inflammation%20and%20Mineral%20Metabolism%20in%20Adults%20with%20Elevated%20Blood%20Pressure&rft.jtitle=The%20Journal%20of%20nutrition&rft.au=Sullivan,%20Valerie%20K&rft.date=2021-10-01&rft.volume=151&rft.issue=10&rft.spage=3067&rft.epage=3074&rft.pages=3067-3074&rft.issn=0022-3166&rft.eissn=1541-6100&rft_id=info:doi/10.1093/jn/nxab236&rft_dat=%3Cproquest_pubme%3E2581072346%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2581072346&rft_id=info:pmid/34293127&rft_oup_id=10.1093/jn/nxab236&rft_els_id=S0022316622003753&rfr_iscdi=true |